Author Question: A home health nurse is visiting an elderly patient with Parkinson's disease. What would the nurse ... (Read 105 times)

vinney12 · **on:** Jul 23, 2018

A home health nurse is visiting an elderly patient with Parkinson's disease. What would the nurse assess this man for related to common adverse effects?

A) Blood dyscrasias
B) Increased dopamine activity
C) Pliability
D) Urinary retention

Question 2

The nursing instructor teaches the students that antineoplastic drugs are often carcinogens. The students are surprised to hear this and ask why. The instructor's best response includes what information?

A) The drugs kill cells resulting in a need for more cellular growth with risk of a mutant cell.
B) These drugs do so much damage to so many human cells that the patient is debilitated.
C) If the patient remains cancer free for 2 years and then cancer is found, it is caused by the drugs.
D) Palliative therapy promotes the growth of new cancer cells because it is not strong enough.

lorealeza · **Reply #1 on:** Jul 23, 2018

Answer to Question 1

D
Feedback:
The nurse would assess the patient for urinary retention because this reaction is caused by loss of muscle tone in the bladder and is most likely to occur in elderly men who have enlarged prostate glands. Parkinson's does not generally cause blood dyscrasias. The nurse cannot assess for increased dopamine activity except to assess for reduced symptoms caused by medication therapy. Pliability is a distracter for this question.

Answer to Question 2

A
Feedback:
Many neoplastic drugs result in the adverse effect of cancer because cell death caused by the agents increase the need for cellular growth, placing the patient at increased risk for a mutant cell to develop. Patients often recover completely from the adverse effects after chemotherapy is completed and do not remain debilitated. Most cancer patients are not considered to be cured until they have remained cancer free for 5 years because no cells have been identified that can remain dormant for 5 years. Palliative therapy does not promote growth of new cancer cells.